[ad_1]
The foundations led by George Soros and Bill Gates have announced the launch of a new initiative, Global Access Health (GAH – Global Access to Health), with the aim of strengthen access to medical technology around the world. For that will purchase from UK company Mologic Ltd, known for devices that fit into the nostrils used to perform rapid tests of Covid-19. The system can also be used to test for dengue, schistosomiasis and river blindness.
The GAH consortium, which includes the Bill & Melinda Gates Foundation and the Soros Economic Development Fund (SEDF), plans invest “at least” 41 million dollars in this agreement, as reported in a press release.
Covid-19 rapid tests allow the world is back to normal, so that bars, restaurants, shops and offices reopen. The system allows people without symptoms to have a quick test to see if they have the virus or not. Many times these tests are needed to get to different places.
The purchase would be the key because “transforms a world-class for-profit business into a social enterprise and this allows you to fully reinvest your earnings in achieving these objectives, ”as a press release from Mologic explains.
“We believe we have the people and skills to meet the challenges and opportunities that lie ahead. And we hope this unique transaction will be an example for others to follow, ”said Mark Davis, CEO of Mologic.
// A Peruvian court said in a ruling that the pandemic was created by Bill Gates, George Soros and the Rockefeller family.
Sean Hinton, CEO of the Soros Foundation, said in a statement that the pandemic “painfully demonstrated fundamental inequalities” in global public health. For this reason, some millionaires with philanthropic businesses are looking to help neediest regions in Latin America, Asia, Africa and Oceania accelerate recovery from the impact generated by the coronavirus.
Mologic was founded in 2003 by Mark Davis and his father, Professor Paul Davis, creator of one of the world’s first home pregnancy tests, Light blue. The company is focused on rapid testing for different diseases which can be instrumental in the treatment of patients around the world.
// Coronavirus figures in Argentina: how the vaccination campaign is progressing and which provinces have the most deaths
His extensive work in developing affordable tests for neglected tropical diseases has been supported by grants from various donors and, more importantly, by the Bill and Melinda Gates Foundation. Mologic’s technology has wide application in markets where rapid and accurate testing can help make a significant difference in patient care and outcomes.
.
[ad_2]
Source link